Automation will help the cell therapy sector reduce production costs, resulting in lower-priced products that increase patient accessibility.

Q3 2025 Management View Jason Kelly, Founder, CEO & Director, emphasized Ginkgo’s mission to "make biology easier to engineer" and outlined three major objectives heading into 2026: delivering ...

The New York Stem Cell Foundation, a $23-million-a-year biomedical nonprofit, was acquired by the Jackson Laboratory as part of a move to expand automation in life sciences research. The acquisition, ...

SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, and ...

The global cell culture waste aspirator market is on a strong upward trajectory, growing from USD 877 million in 2025 to an estimated USD 1,824.5 million by 2035. With a robust compound annual growth ...

FRANKLIN LAKES, N.J., Oct. 8, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Opentrons Labworks, Inc., recognized worldwide for ...

Cell Impact and thyssenkrupp Automation Engineering have entered a Strategic Cooperation Agreement for Joint Market Success ...